Effect of Food and a Monoglyceride Emulsion Formulation on Danazol Bioavailability

In: The Journal of Clinical Pharmacology · 1993 · vol. 33(4) , pp. 381–386 · doi:10.1002/j.1552-4604.1993.tb04673.x · PMID:8473554 · W2048883334
article OA: closed CC0 ⤵ 11 in-corpus citations
View on OpenAlex View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

A lipid emulsion formulation of danazol increased bioavailability fourfold in fasted subjects, while food increased bioavailability threefold for the capsule formulation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The bioavailability of a single 100-mg dose of danazol delivered from the commercial formulation (hard gelatin capsule) and from an experimental lipid emulsion formulation of danazol was studied in 11 healthy female volunteers in both fed and fasted states. The emulsion formulation (fasted) increased bioavailability fourfold compared with the capsule (P = .0001); the difference, however, was not significant in the fed state. Food increased the bioavailability of the capsule formulation more than threefold over fasted administration (P = .0001). In a separate study of 12 female volunteers, single doses of the emulsion formulation of danazol administered with food demonstrated essentially dose-proportional pharmacokinetics over the dose range studied (50-200 mg). The authors conclude that factors that increase the extent of solubilization lead to significant enhancement in the bioavailability of danazol.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (10)

Cited by (11)

Source provenance

openalex
last seen: 2026-05-11T06:42:59.773506+00:00
unpaywall
last seen: 2026-06-23T06:35:03.149509+00:00
License: CC0 · commercial use OK